Vaccine Safety in the Public Eye: How COVID-19 Brought Pharmacovigilance Center-Stage
The coronavirus pandemic ushered in a new era of public ...
Felix Arellano
Global Head of Drug Safety – Roche
Hans van Leeuwen
Global Head of Regulatory Operations – Astellas
Julie Thomas
Vice President, Global Medical Safety Operations – Johnson & Johnson
The coronavirus pandemic ushered in a new era of public ...
Organizations currently utilizing manual pharmacovigilance processing understand that it involves many time-consuming manual activities, but ArisGlobal’s LifeSphere Multivigilance 10 is the future of pharmacovigilance.
A reported 86% of pharmaceutical companies plan to significantly increase their investment in automation technologies over the next five years.
In today's rapidly evolving landscape of medical affairs, stakeholder engagement ...
As part of our commitment to providing the most robust ...
ArisGlobal’s annual Breakthrough is a one-of-a-kind event bringing together industry ...
Learn how exciting new technological innovations are set to impact how regulatory information management teams work in 2024 and beyond.
When selecting an IDMP solution, remember decisions made today will ...
Working in clinical operations at a small or midsized Clinical ...
The management of data within organizations has far-reaching effects, as ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved